Findings showed that 53.8% of patients treated with emapalumab achieved a complete response. The Food and Drug Administration (FDA) has approved Gamifant ® (emapalumab-lzsg) for the treatment of adult ...
The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for emapalumab-Izsg for use in adult and ...
The Zangrilli family (left to right), August, Juliet, Henry, Molly and Gus, of Paoli, Pa. (Courtesy of Molly Zangrilli) From Philly and the Pa. suburbs to South Jersey and Delaware, what would you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results